Daniel Cox
@coxdaniel
Surgeon I PhD in #epigenetics #mitochondria #livertranplant @UniMelbMDHS I former Chair @VERITAS_Collab I Aquarius I Views ➡️ own I 🇬🇧🇦🇺
ID: 20378163
08-02-2009 17:13:59
341 Tweet
321 Takipçi
661 Takip Edilen
Great effort by all, but especially by lead author Daniel Cox! @CoxDaniel TranslationalGenomic mdpi.com/2075-4655/7/2/…
The BEST-Fluids trial has now been published online in The Lancet. Balanced crystalloid IV fluid reduces the incidence of delayed graft function compared with saline in kidney transplantation The Lancet AKTN ANZDATA Registry thelancet.com/journals/lance…
Another brick in the wall in our research to encourage the translation of novel molecular biomarkers to enhance precision & personalisation in liver transplant care..... Thanks for your support and mentorship as always Alex Dobrovic
very fortunate to be guided by 3 very supportive clinical & scientific experts who continue to push me to explore & learn the basic science. thank you. Vijayaragavan Muralidharan Adam Testro TranslationalGenomic. 🧬🥼⚕️ UniMelb MDHS Austin Health
Hugely inspiring session 🔥on the future of machine perfusion at #ESOTcongress this AM from Prof Gabriel Oniscu Paulo Martins MD, PhD, FACS Marcelo Cypel et al. What an exciting time to be an aspiring academic surgeon in Tx. 🥼🧬#perfusiontherapeutics #perfusionpersonalisation
Congratulations Daniel Cox on your exceptional PhD thesis. 👏🏽👏🏽 Very proud to be able to hold the printed volume , a work of scientific art. Glad to have been on this journey with you. The future is extremely bright. Thank you fellow supervisors TranslationalGenomic and Adam Testro.
We're saddened to hear of the passing of A/Prof Alexander Dobrovic Alex Dobrovic. A dedicated cancer researcher and epigeneticist, his lab was at the forefront of bringing epigenetic based tests into the clinic. 1/3
🆕Online today: Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable #pancreaticpancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial Bas Groot Koerkamp, Marc Besselink, Dutch Pancreatic Cancer Group thelancet.com/journals/lanon…